Acceso a Ensayos Clínicos en LMA: Cómo Superar las Principales Barreras de Atención
https://vimeo.com/1156890981 La Dra. Irum Khan, Profesora Asociada de Medicina en Hematología y Oncología en la Northwestern University Feinberg School of Medicine, explica por qué muchos pacientes con leucemia mieloide aguda…
El recorrido de Jeanine con la LMA: Encontrar tu voz después del diagnóstico
https://vimeo.com/1156637249 Después de meses de infecciones inexplicables, agotamiento y señales de advertencia sutiles, a Jeanine le diagnosticaron leucemia mieloide aguda (LMA). En esta historia profundamente personal, comparte cómo aprender a…
Jeanine’s AML Journey: Finding Your Voice After Diagnosis
https://vimeo.com/1156635606 After months of unexplained infections, exhaustion, and subtle warning signs, Jeanine was diagnosed with acute myeloid leukemia (AML). In this deeply personal story, she shares how learning to trust…
Interested in a Myelofibrosis Clinical Trial? Start Here.
https://vimeo.com/1153993163 Considering participating in a myelofibrosis clinical trial but not sure where to start? Dr. Gabriela Hobbs shares advice to help patients and care partners learn about clinical trials—from understanding…
Bone Marrow Transplant for Myelofibrosis | What You Should Know
https://vimeo.com/1153993197 Is bone marrow transplant something you should be asking your healthcare team about now? Dr. Gabriela Hobbs discusses outdated fears around transplant for myelofibrosis, how outcomes have improved significantly,…
Looking Forward | The Evolving Myelofibrosis Treatment Landscape
https://vimeo.com/1153993211 Dr. Gabriela Hobbs provides insight into the future of myelofibrosis care, explaining how research is moving beyond symptom relief toward therapies that target the underlying biology of the condition….
ASH 2025 Update | Myelofibrosis Treatment and Research Findings
https://vimeo.com/1153993264 Dr. Gabriela Hobbs discusses important new developments in myelofibrosis treatment from the American Society of Hematology annual meeting. Dr. Hobbs highlights emerging therapies, novel combination approaches, and encouraging trial…
What Are Myeloma Treatment Options After CAR T-Cell Therapy?
https://vimeo.com/1147680083 What if myeloma returns after CAR T-cell therapy? Dr. Doris Hansen reviews additional options for patients, including repeat CAR-T treatments, bispecific and trispecific immunotherapies, and other emerging drugs in…
Understanding and Managing CAR T-Cell Therapy Side Effects | What You Should Know
https://vimeo.com/1147680103 Dr. Doris Hansen from Moffit Cancer Center shares an overview of the common side effects of CAR T-cell therapy, such as cytokine release syndrome (CRS), low blood counts, and…
Preparing for Myeloma CAR T-Cell Therapy | Advice and Tips From an Expert
Dr. Doris Hansen from Moffitt Cancer Center shares an overview of the testing and evaluations that a myeloma patient may undergo before CAR T-cell therapy. Dr. Hansen also covers practical…
Current and Emerging CAR T-Cell Therapy Treatment Options
https://vimeo.com/1147680145 Dr. Doris Hansen, a myeloma specialist from Moffitt Cancer Center, reviews the two FDA-approved CAR T-cell therapies currently available and how they’re being used earlier in care, and she…
Understanding the Basics | The Goals of Myeloma CAR T-Cell Therapy
https://vimeo.com/1147680029 How does CAR T-cell therapy work and what are the goals? Dr. Doris Hansen, a multiple myeloma specialist at Moffitt Cancer Center, explains how CAR T-cell therapy fights myeloma…